DEF 14A

Company

Evofem Biosciences, Inc.

Filed

March 30, 2020

Period of Report

May 12, 2020

Accession Number

0001618835-20-000069

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →